Business
WuXi Biologics Launches Industry-Leading Digital Twin Platform PatroLab™ Designed to Transform Bioprocessing and Manufacturing
WuXi Biologics (2269.HK), a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), today announced the launch of PatroLabTM, a state-of-the-art digital twin platform designed to transform bioprocess development and manufacturing. By combining advanced real-time process monitoring with Raman-based Process Analytical Technology (PAT) and predictive in-silico modeling, PatroLab™ enables real-time and smarter analytics, proactive control, and accelerated decision-maki
About this update from Wuxi Biologics (cayman) Inc.
[{"type":"text","content":"SHANGHAI, Jan. 12, 2026 /PRNewswire/ -- WuXi Biologics (2269.HK), a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), today announced the launch of PatroLabTM, a state-of-the-art digital twin platform designed to transform bioprocess development and manufacturing. By combining advanced real-time process monitoring with Raman-based Process Analytical Technology (PAT) and predictive in-silico modeling, PatroLab™ enables real-time and smarter analytics, proactive control, and accelerated decision-making. This integrated digital solution helps enhance process performance, minimize process risks, shorten development timelines, and ensure consistent, high-quality biologics manufacturing. With PatroLab™, WuXi Biologics sets a new benchmark for efficiency and reliability, enabling global clients to achieve faster time-to-market and robust commercial supply.","length":903,"tagName":"p"},{"type":"text","content":"Dr. Chris Chen, CEO of WuXi Biologics, commented: "As a leading global digital CRDMO partner, WuXi Biologics aims to turn the complex journey of biologics R&D and manufacturing into a predictable, accelerated success by building an industry-leading digital ecosystem rooted in our biologics expertise. The launch of PatroLabTM is a pivotal milestone, marking a paradigm shift in biologics development and manufacturing. By integrating real-time analytics, machine learning, predictive modeling and automated control into a unified platform, we enable partners to accelerate innovation while achieving unprecedented quality and efficiency. This is more than a technological breakthrough – it's a testament to our steadfast commitment to expediting the delivery of clients' life-saving therapies to patients worldwide."","length":839,"tagName":"p"},{"type":"text","content":"Advanced Raman PAT Revolutionizes Monitoring and Analytics ","length":58,"tagName":"p"},{"type":"text","content":"Central to the PatroLabTM platform is WuXi Biologics' advanced Raman PAT system, which marks a groundbreaking transition from conventional static, off-line testing to real-time, non-invasive monitoring of more than 40 key process performance and product quality attributes. This innovation enables deeper process insights and faster data-driven decisions.","length":359,"tagName":"p"},{"type":"text...